Currently, there are no FDA approved medications for treating fragile X syndrome. That may soon change, thanks to a $11.5 million NIH grant awarded to UC Davis Medical Center. The new funding will allow researchers to test a new drug that is designed to improve language learning for children with fragile X syndrome. UC Davis is one of only two medical centers approved for the drug trail in the nation. Since UC Davis Medical Center is home to the renowned MIND Institute, which hosts the Fragile X Research and Treatment Center, it is a logical choice for the treatment study.Read More
Science Market Update
Tags: CA, California, Research Funding, Drug Development, research grant, UC Davis - Medical Center, Southwest Region, new research grant, UCD, drug evaluation, BioResearch Product Faire, Bioresearch Grant
Traumatic brain injury, or TBI, is the leading cause of disability among U.S. military personnel and veterans. What’s more, 50% of people with TBI develop spontaneous seizures. If the seizures become recurrent then the condition qualifies as Post-Traumatic Epilepsy, PTE. Now thanks to a 3 year, $750,000 research grant from the Department of Defense and the Army, researchers at Texas A&M will conduct a study on TBI to uncover the molecular and epigenetic mechanism of PTE.Read More
The Laboratory of Neuro Imaging at the University of Southern California recently received a $21.7 million research grant from the National Institutes of Health to study epilepsy. Epilepsy is currently incurable, and the research team supported by the recent NIH grant will work toward finding a cure and developing treatments to prevent the condition.Read More
Dr. Gürol Süel, a Molecular Biology professor at the University of California San Diego, has been named a HHMI-Simons Faculty Scholar by the Howard Hughes Medical Institute (HHMI), the Simons Foundation, and the Bill & Melinda Gates Foundation. This prestigious distinction includes a $1.5 million award to support Süel's research study on how bacterial cells use electrical signals to communicate with each other.Read More
(Image of brain by functional MRI via Wikimedia Commons)
Cognitive neurologist, Rosie Cowell of the University of Massachusetts, Amherst received a nearly $600,000 grant from the National Science Foundation. The funding will be used to develop and test her theory of how fine-grained visual perception interacts with the area of the brain critical to memory.Read More
A team of nanoengineers at the University of California San Diego is creating 3D bio-printed liver tissue. This exciting new technology could change the game for researchers developing new medications.Read More
One common trait that all humans and animals share is the need for sleep. Even though sleep is a necessity for humans and animals to properly function, there are many disorders that interfere with sleep, such as insomnia and night terrors. Another disorder that certain animals experience is called "local sleep" where part of the brain sleeps while the animal is still awake. Two big questions researchers have are why this happens, and if it can also occur in humans. (Image courtesy of Wikimedia Commons).Read More
California is home to some serious unicellular research, and the National Institute of Health is taking notice. Bioresearch programs at California institutions accounted for a significant portion of the $7.9 million in grants which the NIH awarded to researchers studying single cells. The request for 2014 applications came from the NIH last December to fund programs related to many areas of cellular biology, including personalized treatment for diseases at a cellular level. The grants are supported by the NIH Common Fund’s Single Cell Analysis Program (SCAP) and represents a major boost for many of the 25 research teams that were chosen to receive funding.Read More
Rockefeller University is a well-funded research institution on the verge of expansion, with a new two-story, 160,000 square foot laboratory building priced at $240 million in the works, a new $25 million research fund established for new techniques in drug discovery and a recent NIH grant for researchers studying vaccine response totaling $2.4 million.
Researchers at the University of Arizona recently received a $1.3 million new life science grant from the National Institutes of Health. The research funding was awarded in April of 2014 by the National Heart, Lung and Blood Institute, a division of the National Institutes of Health. The project, entitled “The Cost-Effectiveness of School-Based Supervised Asthma Therapy” is being led by Dr. Lynn Gerald. Dr. Gerald is the Canyon Ranch Endowed Chair, Professor, and a Scientist in the Department of Health Promotion Sciences in the College of Public Health at the University of Arizona. In addition to this project receiving NIH research funding, her research interests include clinical, behavioral and epidemiological research in asthma, COPD, and tuberculosis.